HPV testing in patients with low grade cervical cytological abnormalities: A follow up study

Journal of Clinical Pathology

Volumn 49, Issue 6, 1996, Pages 493-496

  Herrington, C S ^a,b   Evans, M F ^a   Charnock, F M ^a   Gray, W ^a   McGee, J O'D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cytology; Human papillomavirus; In situ hybridisation; Polymerase chain reaction

Indexed keywords

ADULT; ARTICLE; BASE PAIRING; CANCER GRADING; CYTOLOGY; FEMALE; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0029930692     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.6.493     Document Type: Article

References (21)

1. Oxford Regional Health Authority. National Co-ordinating Network Report. NHS Cervical Screening Programme. Oxford: Oxford Regional Health Authority, 1992.
2. Herrington CS. Human papillomaviruses in cervical neoplasia I: classification, virology, pathology and epidemiology. J Clin Pathol 1994;47:1066-72.
3. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1993;79:328-37.
4. Meijer CJLM, van den Brule AJ , Snijders PJ, Helmerhorst T, Kenemans P, Walboomers JMM. Detection of human papillomavirus in cervcal scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ 1992;119:271-81.
5. Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 1993;67:602-5.
6. Schiffman M. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394 8.
7. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell M, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervicalin-traepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
8. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson MC. Human papillomavirus type 16 DNA in cervical smears as predictor of high grade cervical intraepithelial neoplasia. Lancet 1992;339:959-60.
9. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
10. Herrington CS, Evans MF, Hallam NF, Charnock FM, Gray W, McGee JO'D. HPV status in the prediction of high grade CIN in patients with persistent low grade cervical cytological abnormalities. Br J Cancer 1995; 71:206-9.
11. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-6.
12. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cell of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
13. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JO'D, eds. Diagnostic molecular pathology: a practical approach. Vol 2. Oxford: Oxford University Press, 1992:131 52.
14. Coleman DV, Evans DMD. Biopsy pathology and cytology of the cervix. London: Chapman and Hall, 1988.
15. Herrington CS, de Angelis M, Evans ME, Troncone G, McGee JO'D. Detection of high risk human papillomavirus in routine cervical smears: strategy for screening. J Clin Pathol 1992;45:385-90.
16. Herrington CS, Graham AK, McGee JO'D. Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines. J Clin Pathol 1991;44:33-8.
17. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd edn. Boston: Little Brown, 1991.
18. Graham AK, Herrington CS, McGee JO'D. Sensitivity and specificity of monoclonal antibodies to human papillomavirus type 16 capsid protein: comparison with simultaneous viral detection by non-isotopic in situ hybridisation. J Clin Pathol 1991;44:96-101.
19. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
20. Hirschowitz L, Raffle AE, Mackenzie EF, Hughes AO. Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ 1992;304:1209-12.
21. Buckley CH, Herbert A, Johnson J, Mackenzie EFD, Smith JHF, Smith PA, et al. Borderline nuclear changes in cervical smears: guidelines on their recognition and management. J Clin Pathol 1994;47:481 92.